• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings

    7/14/23 10:12:38 AM ET
    $AIMD
    $BTB
    $EDTX
    $JPM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Restaurants
    Consumer Discretionary
    Get the next $AIMD alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Friday.

    Following the market opening Friday, the Dow traded up 0.47% to 34,555.27 while the NASDAQ rose 0.36% to 14,189.30. The S&P 500, also rose, gaining, 0.27% to 4,522.01.

    Check This Out: Robinhood, Pinterest And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    • Health care shares climbed by 1.4% on Friday.
    • In trading on Friday, energy shares fell by 1.8%.

     

    Top Headline

    JPMorgan Chase & Co. (NYSE:JPM) reported better-than-expected second-quarter financial results.

    JPMorgan reported net revenue (managed) of $42.4 billion, up 34.1% year-over-year, beating the consensus of $38.96 billion. Adjusted EPS was $4.37, beating the consensus of $3.99.

     

    Equities Trading UP

    • PainReform Ltd. (NASDAQ:PRFX) shares shot up 79% to $10.29. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
    • Shares of Ainos, Inc. (NASDAQ:AIMD) got a boost, shooting 48% to $1.0799 after gaining around 7% on Thursday.
    • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares were also up, gaining 46% to $63.24 after jumping 203% on Thursday.

     

    Equities Trading DOWN

    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) shares dropped 68% to $3.0650 after the company announced discontinuing enrollment in Phase 1/2 study and terminating development of THE-630 for gastrointestinal stromal tumors following two dose-limiting toxicities.
    • Shares of Bit Brother Limited (NASDAQ:BTB) were down 37% to $0.4901 after the company announced pricing of a $50 million registered direct offering.
    • Leslie's, Inc. (NASDAQ:LESL) was down, falling 33% to $6.40 after the company released preliminary results for its fiscal third quarter and announced a CFO transition. The company said it expects fiscal third-quarter revenue to come in at $611 million versus estimates of $703.74 million and seed adjusted earnings in a range of 39 cents to 41 cents per share versus estimates of 69 cents per share. Leslie's also announced that CFO Steve Weddell is stepping down from his role, effective Aug. 7.

    Also Check This Out: Ethereum Tops $2,000; XRP Emerges As Top Gainer

     

    Commodities

    In commodity news, oil traded down 0.6% to $76.42 while gold traded up 0.1% at $1,964.20.

    Silver traded up 1% to $25.205 on Friday while copper rose 0.1% to $3.9415.

     

    Euro zone

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.3% while Spain’s IBEX 35 Index slipped 0.1% The German DAX declined 0.1% French CAC 40 gained 0.3% and Italy’s FTSE MIB Index fell 0.1%.

    Italy recorded a trade surplus of EUR 4.7 billion in May versus a year-ago gap of EUR 62 million. Germany's wholesale prices declined for the third straight month to 2.9% year-over-year in June.

     

    Asia Pacific Markets

    Asian markets closed mostly higher on Friday, with Japan’s Nikkei 225 declining 0.09%, Hong Kong’s Hang Seng Index gaining 0.33%, China’s Shanghai Composite Index rising 0.04%. India’s S&P BSE Sensex rose 0.4%.

    India's wholesale prices declined by 4.12% year-over-year in June versus a 3.48% drop in the previous month, while domestic passenger vehicle sales in India rose by 1.6% year-over-year to 280,252 in June. Industrial production in Japan fell by 2.2% month-over-month in May versus the flash reading of a 1.6% decline.

     

    Economics

    • Export prices in the U.S. fell 0.9% month-over-month in June versus a 1.9% decline in May.
    • Import prices in the U.S. fell 0.2% month-over-month in June versus a revised 0.4% decline in May.

    Now Read This: Top 5 Real Estate Stocks That May Plunge In July

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,373,570 cases with around 1,168,610 deaths. India confirmed a total of at least 44,994,760 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 691,451,110 cases of COVID-19 worldwide with more than 6,899,350 deaths.

    Get the next $AIMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIMD
    $BTB
    $EDTX
    $JPM

    CompanyDatePrice TargetRatingAnalyst
    JP Morgan Chase & Co.
    $JPM
    3/26/2026$310.00Hold
    Jefferies
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    Leslie's Inc.
    $LESL
    1/15/2026$1.50Equal-Weight → Underweight
    Morgan Stanley
    JP Morgan Chase & Co.
    $JPM
    1/7/2026Outperform → Peer Perform
    Wolfe Research
    JP Morgan Chase & Co.
    $JPM
    7/9/2025$327.00Mkt Perform → Outperform
    Keefe Bruyette
    JP Morgan Chase & Co.
    $JPM
    7/8/2025$259.00Hold → Reduce
    HSBC Securities
    JP Morgan Chase & Co.
    $JPM
    6/27/2025$235.00Neutral → Underperform
    Robert W. Baird
    JP Morgan Chase & Co.
    $JPM
    5/15/2025$305.00Buy
    TD Cowen
    More analyst ratings

    $AIMD
    $BTB
    $EDTX
    $JPM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on JPMorgan Chase with a new price target

    Jefferies initiated coverage of JPMorgan Chase with a rating of Hold and set a new price target of $310.00

    3/26/26 8:49:56 AM ET
    $JPM
    Major Banks
    Finance

    JPMorgan Chase upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded JPMorgan Chase from Underperform to Neutral and set a new price target of $280.00

    2/3/26 6:50:14 AM ET
    $JPM
    Major Banks
    Finance

    Leslie's downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Leslie's from Equal-Weight to Underweight and set a new price target of $1.50

    1/15/26 8:33:55 AM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    $AIMD
    $BTB
    $EDTX
    $JPM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tsai Chun-Jung

    4 - Ainos, Inc. (0001014763) (Issuer)

    4/17/26 4:17:09 PM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Tsai Chun-Hsien

    4 - Ainos, Inc. (0001014763) (Issuer)

    4/17/26 4:15:14 PM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Lee Ting-Chuan

    4 - Ainos, Inc. (0001014763) (Issuer)

    4/17/26 4:15:13 PM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIMD
    $BTB
    $EDTX
    $JPM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Ase Test, Inc. bought 29,476 shares (SEC Form 4)

    4 - Ainos, Inc. (0001014763) (Issuer)

    6/25/25 6:03:05 AM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Iskander Anthony A bought $49,916 worth of shares (63,995 units at $0.78), increasing direct ownership by 3,200% to 65,995 units (SEC Form 4)

    4 - Leslie's, Inc. (0001821806) (Issuer)

    5/15/25 4:05:40 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    Director Ofarrell Susan C bought $25,200 worth of shares (31,500 units at $0.80), increasing direct ownership by 71% to 75,763 units (SEC Form 4)

    4 - Leslie's, Inc. (0001821806) (Issuer)

    5/14/25 4:05:11 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    $AIMD
    $BTB
    $EDTX
    $JPM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    JPMorganChase Expands Security and Resiliency Initiative Across Europe

    Broader geographic focus builds on momentum in the U.S. and reinforces commitment to strengthening critical supply chains, economic resilience and shared security across trading partners JPMorganChase today announced the expansion of its $1.5 trillion, 10-year Security and Resiliency Initiative (SRI) — which seeks to facilitate, finance and invest in industries vital to economic security — across Europe. Building on the initiative's momentum in the U.S. and previously announced intention to expand to the U.K., the announcement underscores JPMorganChase's commitment to strengthening supply chains and supporting industries critical to innovation and growth. "The national and economic secu

    4/21/26 12:00:00 AM ET
    $JPM
    Major Banks
    Finance

    JPMorganChase 2026 Annual Meeting of Shareholders

    As previously announced, the JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") annual meeting of shareholders will be held on Tuesday, May 19, 2026 at 10:00 a.m. (Eastern). The meeting will be held virtually. Attending the annual meeting To participate in the virtual meeting, visit http://www.virtualshareholdermeeting.com/JPM2026 and enter the 16-digit control number included on your proxy card, voting instruction form or notice you previously received. Shareholders may submit questions either before the meeting, from April 22, 2026 through May 13, 2026, or during a portion of the meeting. If you wish to submit a question before the meeting, you may log into www.proxyvot

    4/15/26 4:32:00 PM ET
    $JPM
    Major Banks
    Finance

    JPMorganChase Declares Preferred Stock Dividends

    JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm's Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.9 trillion in assets and $364 billion in stockholders' equity as of March 31, 2026. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and

    4/15/26 4:31:00 PM ET
    $JPM
    Major Banks
    Finance

    $AIMD
    $BTB
    $EDTX
    $JPM
    SEC Filings

    View All

    JP Morgan Chase & Co. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - JPMORGAN CHASE & CO (0000019617) (Filer)

    4/24/26 4:16:13 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    4/23/26 8:10:18 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form 8-K filed by JP Morgan Chase & Co.

    8-K - JPMORGAN CHASE & CO (0000019617) (Filer)

    4/23/26 4:15:28 PM ET
    $JPM
    Major Banks
    Finance

    $AIMD
    $BTB
    $EDTX
    $JPM
    Leadership Updates

    Live Leadership Updates

    View All

    JPMorganChase Partners With Sports Legends to Help Athletes Master Their Money

    Athlete Council to guide JPMorganChase in new programs for athletes JPMorganChase today announced a new initiative to help athletes navigate every aspect of their financial lives, from early career stages through retirement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318551874/en/Names listed in photo order from left to right for each row. Building on the firm's extensive banking and wealth planning and management expertise, the JPMorganChase Athlete Council brings together some of the world's most accomplished sports figures who will meet with JPMorganChase leaders on a periodic basis to discuss the unique financial ne

    3/18/26 12:30:00 PM ET
    $JPM
    Major Banks
    Finance

    J.P. Morgan Asset Management Bolsters Commitment to Private Wealth Alternatives with Senior Hires

    Stephanie Davis joins as Head of Private Wealth Alternatives from Hamilton LaneSean Flynn tapped as Private Wealth Alternatives National Manager  NEW YORK, March 3, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Stephanie Davis as Head of Private Wealth Alternatives, leading an increased focus on serving financial advisors across the U.S. Stephanie brings three decades of experience, most recently as Co-Head of U.S. Private Wealth Solutions at Hamilton Lane. Based in New York, she will report to Steve Lundquist, Head of U.S. Advisor. In her

    3/3/26 9:30:00 AM ET
    $JPM
    Major Banks
    Finance

    J.P. Morgan Asset Management Welcomes Pam Hess as Retirement Strategist

    Experienced retirement research expert to help meet increased demand for actionable retirement insights NEW YORK, Jan. 27, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Pam Hess as Executive Director and Retirement Strategist on the Retirement Insights team reporting to Michael Conrath, Chief Retirement Strategist. This key hire reflects the firm's ongoing commitment to investing in resources that help financial professionals, participants and plan sponsors navigate today's complex retirement landscape. In this role, Pam supports the deve

    1/27/26 10:00:00 AM ET
    $JPM
    Major Banks
    Finance

    $AIMD
    $BTB
    $EDTX
    $JPM
    Financials

    Live finance-specific insights

    View All

    JPMorganChase Declares Preferred Stock Dividends

    JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm's Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.9 trillion in assets and $364 billion in stockholders' equity as of March 31, 2026. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and

    4/15/26 4:31:00 PM ET
    $JPM
    Major Banks
    Finance

    PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

    LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strategy DeepSolar advances from acquisition to early commercial deployment TEL AVIV, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today provided a business update for the year ended December 31, 2025, in conjunction with the filing of its Annual Report on Form 20-F. 2025 and early 2026 Highlights Completed the strategic acquisition of DeepSolar, expanding PRF into AI-driven solar analytics and establishing a second high-growth operating platform.Completed a majority investment in LayerBio, adding OcuRing™-K, a patented drop-less, susta

    3/27/26 8:00:00 AM ET
    $PRFX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    J.P. Morgan Debuts Equity Premium Yield ETFs ROCY and ROCQ on Nasdaq

    New Active ETFs Expand Innovative Derivative Income Suite NEW YORK, March 19, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of two new active ETFs on the Nasdaq Exchange as part of the firm's landmark derivative income suite, the JPMorgan Equity Premium Yield ETF (ROCY) and the JPMorgan Nasdaq Equity Premium Yield ETF (ROCQ). With the introduction of ROCY and ROCQ, J.P. Morgan is now the only ETF provider offering a comprehensive suite of actively managed derivative income strategies, with three distinct methods of treating options premium.Led by H

    3/19/26 12:30:00 PM ET
    $JPM
    Major Banks
    Finance

    $AIMD
    $BTB
    $EDTX
    $JPM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ainos Inc.

    SC 13D/A - Ainos, Inc. (0001014763) (Subject)

    11/27/24 6:08:44 AM ET
    $AIMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by PainReform Ltd.

    SC 13G/A - PAINREFORM LTD. (0001801834) (Subject)

    11/14/24 4:25:42 PM ET
    $PRFX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Leslie's Inc.

    SC 13G/A - Leslie's, Inc. (0001821806) (Subject)

    11/13/24 4:05:17 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary